Search Results - "Lawrie, Alison M"
-
1
Alternate aerosol and systemic immunisation with a recombinant viral vector for tuberculosis, MVA85A: A phase I randomised controlled trial
Published in PLoS medicine (30-04-2019)“…There is an urgent need for an effective tuberculosis (TB) vaccine. Heterologous prime-boost regimens induce potent cellular immunity. MVA85A is a candidate TB…”
Get full text
Journal Article -
2
Phase Ia clinical evaluation of the safety and immunogenicity of the Plasmodium falciparum blood-stage antigen AMA1 in ChAd63 and MVA vaccine vectors
Published in PloS one (21-02-2012)“…Traditionally, vaccine development against the blood-stage of Plasmodium falciparum infection has focused on recombinant protein-adjuvant formulations in order…”
Get full text
Journal Article -
3
Prime and target immunization protects against liver-stage malaria in mice
Published in Science translational medicine (26-09-2018)“…Despite recent advances in treatment and vector control, malaria is still a leading cause of death, emphasizing the need for an effective vaccine. The malaria…”
Get more information
Journal Article -
4
Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination
Published in Med (New York, N.Y. : Online) (11-06-2021)“…Development of an effective vaccine against the pathogenic blood-stage infection of human malaria has proved challenging, and no candidate vaccine has affected…”
Get more information
Journal Article -
5
Safety, Immunogenicity and Efficacy of Prime-Boost Vaccination with ChAd63 and MVA Encoding ME-TRAP against Plasmodium falciparum Infection in Adults in Senegal
Published in PloS one (15-12-2016)“…Malaria transmission is in decline in some parts of Africa, partly due to the scaling up of control measures. If the goal of elimination is to be achieved,…”
Get full text
Journal Article -
6
A phase Ia study to assess the safety and immunogenicity of new malaria vaccine candidates ChAd63 CS administered alone and with MVA CS
Published in PloS one (18-12-2014)“…Plasmodium falciparum (P. falciparum) malaria remains a significant cause of mortality and morbidity throughout the world. Development of an effective vaccine…”
Get full text
Journal Article -
7
Impact on malaria parasite multiplication rates in infected volunteers of the protein-in-adjuvant vaccine AMA1-C1/Alhydrogel+CPG 7909
Published in PloS one (22-07-2011)“…Inhibition of parasite growth is a major objective of blood-stage malaria vaccines. The in vitro assay of parasite growth inhibitory activity (GIA) is widely…”
Get full text
Journal Article -
8
Safety and Immunogenicity of ChAd63/MVA Pfs25-IMX313 in a Phase I First-in-Human Trial
Published in Frontiers in immunology (14-07-2021)“…Transmission blocking vaccines targeting the sexual-stages of the malaria parasite could play a major role to achieve elimination and eradication of malaria…”
Get full text
Journal Article -
9
Optimising Controlled Human Malaria Infection Studies Using Cryopreserved P. falciparum Parasites Administered by Needle and Syringe
Published in PloS one (18-06-2013)“…Controlled human malaria infection (CHMI) studies have become a routine tool to evaluate efficacy of candidate anti-malarial drugs and vaccines. To date, CHMI…”
Get full text
Journal Article -
10
Combining Viral Vectored and Protein-in-adjuvant Vaccines Against the Blood-stage Malaria Antigen AMA1: Report on a Phase 1a Clinical Trial
Published in Molecular therapy (01-12-2014)“…The development of effective vaccines against difficult disease targets will require the identification of new subunit vaccination strategies that can induce…”
Get full text
Journal Article -
11
Safety and immunogenicity of heterologous prime-boost immunisation with Plasmodium falciparum malaria candidate vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in healthy Gambian and Kenyan adults
Published in PloS one (19-03-2013)“…Heterologous prime boost immunization with chimpanzee adenovirus 63 (ChAd63) and Modified vaccinia Virus Ankara (MVA) vectored vaccines is a strategy recently…”
Get full text
Journal Article -
12
Repeat controlled human malaria infection of healthy UK adults with blood-stage Plasmodium falciparum: Safety and parasite growth dynamics
Published in Frontiers in immunology (22-08-2022)“…In endemic settings it is known that natural malaria immunity is gradually acquired following repeated exposures. Here we sought to assess whether similar…”
Get full text
Journal Article -
13
Controlled human malaria infection with a clone of Plasmodium vivax with high-quality genome assembly
Published in JCI insight (08-12-2021)“…Controlled human malaria infection (CHMI) provides a highly informative means to investigate host-pathogen interactions and enable in vivo proof-of-concept…”
Get full text
Journal Article -
14
Safety and Immunogenicity of Malaria Vectored Vaccines Given with Routine Expanded Program on Immunization Vaccines in Gambian Infants and Neonates: A Randomized Controlled Trial
Published in Frontiers in immunology (20-11-2017)“…Heterologous prime-boost vaccination with chimpanzee adenovirus 63 (ChAd63) and modified vaccinia virus Ankara (MVA) encoding multiple epitope string…”
Get full text
Journal Article -
15
Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine
Published in Vaccines (Basel) (15-05-2019)“…Adenovirus vectored vaccines are a highly effective strategy to induce cellular immune responses which are particularly effective against intracellular…”
Get full text
Journal Article -
16
Safety and Immunogenicity of Adenovirus and Poxvirus Vectored Vaccines against a Mycobacterium Avium Complex Subspecies
Published in Vaccines (Basel) (16-03-2021)“…Heterologous prime-boost strategies are known to substantially increase immune responses in viral vectored vaccines. Here we report on safety and…”
Get full text
Journal Article -
17
Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation
Published in Nature communications (28-11-2013)“…Induction of antigen-specific CD8 + T cells offers the prospect of immunization against many infectious diseases, but no subunit vaccine has induced CD8 + T…”
Get full text
Journal Article -
18
Clinical Assessment of a Recombinant Simian Adenovirus ChAd63: A Potent New Vaccine Vector
Published in The Journal of infectious diseases (01-03-2012)“…Background. Vaccine development in human Plasmodium falciparum malaria has been hampered by the exceptionally high levels of CD8⁺ T cells required for…”
Get full text
Journal Article -
19
Safety and High Level Efficacy of the Combination Malaria Vaccine Regimen of RTS,S/AS01B With Chimpanzee Adenovirus 63 and Modified Vaccinia Ankara Vectored Vaccines Expressing ME-TRAP
Published in The Journal of infectious diseases (01-09-2016)“…The need for a highly efficacious vaccine against Plasmodium falciparum remains pressing. In this controlled human malaria infection (CHMI) study, we assessed…”
Get full text
Journal Article -
20
Demonstration of the Blood-Stage Plasmodium falciparum Controlled Human Malaria Infection Model to Assess Efficacy of the P. falciparum Apical Membrane Antigen 1 Vaccine, FMP2.1/AS01
Published in The Journal of infectious diseases (01-06-2016)“…Background. Models of controlled human malaria infection (CHMI) initiated by mosquito bite have been widely used to assess efficacy of preerythrocytic vaccine…”
Get full text
Journal Article